Smartphone App Tested for Psychological Wellbeing in Crohn's Disease
Tests a smartphone app for stress and wellbeing in adults with Crohn's disease.
Plain-language title generated from the registry record
Registry title: A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Key facts
- Where
- Beersheba, Haifa, Petah Tikva, and Ramat Gan, IsraelSee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06221254, who can take part
Where in Israel
- Soroka University Medical CenterBeersheba, IsraelTaking people
- Rambam Health Care Campus iHaifa, IsraelNot yet recruiting
- Belinson Medical CenterPetah Tikva, IsraelNot yet recruiting
- Sheba medical centerRamat Gan, IsraelNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Soroka University Medical Center
- Trial code
- NCT06221254
- Record updated
- 30 April 2026
- Original description
Psychological intervention by COBMINDEX application to reduce psychological stress among CD patients, fatigue and pain and improve the patients' well being, quality-of-life and disease-coping skills, as well as improvement of the patients' immunological profile and intestinal microbiome.Read full original descriptionShow less
Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Goes Forward- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Psychological intervention by COBMINDEX application to reduce psychological stress among CD patients, fatigue and pain and improve the patients' well being, quality-of-life and disease-coping skills, as well as improvement of the patients' immunological profile and intestinal microbiome.
Inclusion: Willingness to participate and signed informed consent; Hebrew-speaking; Age 18-75; Proven diagnosis of Crohn's disease, at least 3 months post-diagnosis; Stable medical treatment for the last 3 months; Any Harvey Bradshaw Index score; Ability to operate a smartphone and cellular application.
Exclusion: Alcohol or drug dependency (stable medical use of cannabinoids will be allowed); Diagnosis of ulcerative colitis or unclassified inflammatory bowel disease; Planned surgery for Crohn's disease; Surgery for Crohn's disease (excluding drainage of perianal abscess) in the last 3 months; Psychiatric disease (schizophrenia, major depression or bipolar disorder); Pregnancy or planned pregnancy during study period; Clinically significant comorbidity; Former participation in COBMINDEX trials.